Francesca Bonello

793 total citations
18 papers, 181 citations indexed

About

Francesca Bonello is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Francesca Bonello has authored 18 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Francesca Bonello's work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (11 papers) and Peptidase Inhibition and Analysis (7 papers). Francesca Bonello is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (11 papers) and Peptidase Inhibition and Analysis (7 papers). Francesca Bonello collaborates with scholars based in Italy, Switzerland and Netherlands. Francesca Bonello's co-authors include Mario Boccadoro, Francesca Gay, Roberto Mina, Mattia D’Agostino, Sara Bringhen, Alessandra Larocca, Marco Salvini, Chiara Cerrato, Antonio Palumbo and Valeria Magarotto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancers.

In The Last Decade

Francesca Bonello

17 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Bonello Italy 9 143 105 103 28 25 18 181
Pia Sondergeld Germany 4 220 1.5× 135 1.3× 139 1.3× 24 0.9× 17 0.7× 4 252
Caleb K. Stein United States 5 62 0.4× 67 0.6× 55 0.5× 41 1.5× 32 1.3× 9 128
Wolney Barreto Brazil 6 155 1.1× 106 1.0× 125 1.2× 14 0.5× 16 0.6× 10 194
Silvia De Santis Italy 7 231 1.6× 32 0.3× 222 2.2× 18 0.6× 22 0.9× 15 294
Yunsi Olyslager United States 8 108 0.8× 153 1.5× 100 1.0× 21 0.8× 28 1.1× 14 180
Ana-Isabel Teruel Spain 3 175 1.2× 84 0.8× 140 1.4× 15 0.5× 12 0.5× 3 181
Laura Rosiñol Spain 5 152 1.1× 89 0.8× 94 0.9× 14 0.5× 10 0.4× 18 159
Christopher Maisel United States 7 89 0.6× 53 0.5× 79 0.8× 12 0.4× 5 0.2× 20 127
Irene Aires‐Mejía Spain 2 99 0.7× 59 0.6× 68 0.7× 5 0.2× 5 0.2× 2 130
Omar Saavedra Spain 9 30 0.2× 66 0.6× 86 0.8× 11 0.4× 36 1.4× 22 167

Countries citing papers authored by Francesca Bonello

Since Specialization
Citations

This map shows the geographic impact of Francesca Bonello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Bonello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Bonello more than expected).

Fields of papers citing papers by Francesca Bonello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Bonello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Bonello. The network helps show where Francesca Bonello may publish in the future.

Co-authorship network of co-authors of Francesca Bonello

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Bonello. A scholar is included among the top collaborators of Francesca Bonello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Bonello. Francesca Bonello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bonello, Francesca, Serena Rocchi, Gregorio Barilà, et al.. (2022). Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma. Frontiers in Oncology. 12. 851864–851864. 11 indexed citations
2.
Bonello, Francesca, et al.. (2022). Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting. Frontiers in Oncology. 12. 830922–830922. 10 indexed citations
3.
Mina, Roberto, Francesca Bonello, & Stefania Oliva. (2021). Minimal Residual Disease in Multiple Myeloma. The Cancer Journal. 27(3). 247–255. 6 indexed citations
4.
Ferrero, Dario, Francesca Bonello, Stefania Oliva, Francesca Gay, & Mario Boccadoro. (2021). Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?. Leukemia Research. 107. 106592–106592.
5.
Mina, Roberto, Francesca Bonello, Francesca Gay, Elena Zamagni, & Mario Boccadoro. (2020). Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report. Clinical Lymphoma Myeloma & Leukemia. 21(1). e21–e24. 2 indexed citations
6.
Mina, Roberto, Francesca Bonello, Maria Teresa Petrucci, et al.. (2020). Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies. Haematologica. 106(4). 1079–1085. 9 indexed citations
7.
Bonello, Francesca, Mariella Grasso, Mattia D’Agostino, et al.. (2020). The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma. Pharmaceuticals. 14(1). 20–20. 10 indexed citations
8.
Bonello, Francesca, Mario Boccadoro, & Alessandra Larocca. (2020). Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients. Cancers. 12(11). 3106–3106. 14 indexed citations
9.
Bertamini, Luca, Francesca Bonello, Mario Boccadoro, & Sara Bringhen. (2020). New drugs in early development for treating multiple myeloma: all that glitters is not gold. Expert Opinion on Investigational Drugs. 29(9). 989–1004. 5 indexed citations
10.
Bonello, Francesca, Roberto Mina, Mario Boccadoro, & Francesca Gay. (2019). Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma. Cancers. 12(1). 15–15. 38 indexed citations
11.
Bonello, Francesca, et al.. (2019). Moving Toward Continuous Therapy in Multiple Myeloma. SHILAP Revista de lepidopterología. 1(4). 189–189. 4 indexed citations
12.
Bonello, Francesca, et al.. (2018). CD38 as an immunotherapeutic target in multiple myeloma. Expert Opinion on Biological Therapy. 18(12). 1209–1221. 30 indexed citations
13.
Salvini, Marco, Mattia D’Agostino, Francesca Bonello, Mario Boccadoro, & Sara Bringhen. (2018). Determining treatment intensity in elderly patients with multiple myeloma. Expert Review of Anticancer Therapy. 18(9). 917–930. 8 indexed citations
14.
Bonello, Francesca, et al.. (2017). How is patient care for multiple myeloma advancing?. Expert Review of Hematology. 10(6). 551–561. 9 indexed citations
15.
Bringhen, Sara, Stefania Oliva, Anna Marina Liberati, et al.. (2017). Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients: A Multicenter, Open Label Phase 1/2 Study. Clinical Lymphoma Myeloma & Leukemia. 17(1). e59–e59. 2 indexed citations
16.
Bringhen, Sara, Valeria Magarotto, Anna Marina Liberati, et al.. (2016). A Multicenter, Open Label Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (MM) Patients. Blood. 128(22). 1145–1145. 7 indexed citations
17.
Salvini, Marco, Francesca Bonello, Mario Boccadoro, & Alessandra Larocca. (2016). Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma. Expert Review of Anticancer Therapy. 17(1). 75–87. 1 indexed citations
18.
Magarotto, Valeria, Marco Salvini, Francesca Bonello, Sara Bringhen, & Antonio Palumbo. (2015). Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins. Leukemia & lymphoma. 57(3). 537–556. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pia Sondergeld Breakdown of academic impact, for papers by Caleb K. Stein Breakdown of academic impact, for papers by Wolney Barreto Breakdown of academic impact, for papers by Silvia De Santis Breakdown of academic impact, for papers by Yunsi Olyslager Breakdown of academic impact, for papers by Ana-Isabel Teruel Breakdown of academic impact, for papers by Laura Rosiñol Breakdown of academic impact, for papers by Christopher Maisel Breakdown of academic impact, for papers by Irene Aires‐Mejía Breakdown of academic impact, for papers by Omar Saavedra
Rankless by CCL
2026